Introduction
Two novel and unique sequences belonging to a previously unidentified human virus were detected in a Kaposi's sarcoma lesion during a search for an infectious agent in acquired immunodeficiency syndrome (AIDS)-associated malignancies. 1 These sequences marked a new human herpes virus that was given the descriptive designation Kaposi's sarcomaassociated herpes virus (KSHV) and was later also termed human herpes virus-8 (HHV-8).
Beside its consistent presence in AIDS-and non-AIDSrelated Kaposi's sarcoma, this virus was isolated from tumor cells and peripheral blood mononuclear cells from patients with primary effusion lymphoma (PEL; also termed body cavity-based lymphoma, BCBL), Castleman's disease and recently also in several disorders of terminal B cell differentiation including multiple myeloma, amyloidosis, Waldenströ m's macroglobulinemia and plasmacytoma (here in the bone marrow stromal cells only). [2] [3] [4] PEL is now unanimously recognized as a unique nosologic entity with distinctive biological and pathological features. The malignant cells are always infected with HHV-8, commonly but not always co-infected with Epstein-Barr virus (EBV). PEL occurs predominantly in human immunodeficiency virus (HIV)-infected patients, but was also described in HIV-negative cases. The PEL cells, however, are consistently HIV-negative (reviewed in Refs 5 and 6).
The initial sequence analysis data showing partial homology of HHV-8 to herpes virus saimiri (HVS; a squirrel monkey virus causing fulminant T cell lymphomas in primates other than its natural hosts) and to EBV (well known to immortalize B cells in vitro and being associated with malignant lymphomas, eg Burkitt lymphoma) suggested that HHV-8 is a lymphotropic herpes virus. All three viruses are members of the gamma subfamily of herpes viruses. Since EBV and HVS are involved in the development of malignant lymphomas, it is quite possible that HHV-8 is also a transforming virus that may well play a thus far unknown role in the genesis of PEL. Recent observations indicate that HHV-8 encodes functional homologues of cytokines, the anti-apoptosis proto-oncogene Bcl-2, the cell cycle regulator cyclin D, as well as other genes putatively affecting cell growth, 7 thus possibly contributing to the growth and spread of malignant cells. Several cell lines have been established from patients with PEL/BCBL which have provided useful tools for studying the biology of this new virus. 8 The aim of the present study was to investigate the frequency of HHV-8 infection in a large panel of continuous human tumor cell lines, derived from solid tumors and hematopoietic malignancies. Given the high prevalence of HHV-8 infection of malignant cells in body effusions, we studied a large number of cell lines derived from malignant pleural effusions and ascitic fluid. In the light of the above-mentioned lymphotropy of HHV-8 and its relatedness to EBV, we examined in particular an extended panel of B cell tumor-derived cell lines. Several PEL-derived cell lines were analyzed as well.
Materials and methods

Culture of cell lines
Except for the PEL cell lines (BC-1, BC-2, BC-3, CRO-AP2, CRO-AP3, CRO-AP5, HBL-6) [8] [9] [10] [11] and several Hodgkin disease-derived cell lines (CO, SBH-1, SUP-HD1), all continuous cell lines tested were taken from the stock of the DSMZ cell bank (details on the positive and negative cell lines will be made available upon request). The characteristics of the cell lines, information on the patient from which they were derived, growth media and references are provided in the DSMZ catalogue. 12 Cell lines were grown at 37°C in a humidified atmosphere of air containing 5% CO 2 . The basal growth media (Life Technologies, Eggenstein, Germany) were supplemented with 5-20% heat-inactivated (at 56°C for 45 min) fetal bovine serum (Sigma, Deisenhofen, Germany). Quality and identity controls were performed as described elsewhere. 12 Cultures were passaged according to standard procedures; all cell lines were examined daily in their culture vessels under an inverted microscope. Cells were harvested and used for experiments in their logarithmic growth phase with viabilities exceeding 90% as determined by trypan blue dye exclusion. 
Polymerase chain reaction (PCR)
PCR was performed as described in detail previously. 13 The primers applied are outlined in Table 1 . One microgram genomic DNA was diluted with PCR buffer (10 × 500 mM KCl, 15 mM MgCl 2 , 100 mM Tris-HCl pH 8.8, 0.8% Nonidet P40) containing 10 pmol of each upstream and downstream primer, 5 nmol of dNTP mix and 1.25 U of Taq DNA polymerase (Qiagen, Hilden, Germany) for the PCR reaction. The PCR reactions were performed with a DNA thermal cycler (Perkin Elmer Cetus, Heidelberg, Germany) under the following conditions: denaturation for 7 min at 95°C; 3 min at 75°C and addition of the Taq polymerase to perform a hot-start PCR; 2 min at 50-65°C (see Table 1 ) and 10 min at 72°C for one cycle. The amplification was carried out in 35 cycles of 30 s at 94°C, 30 s at 50-65°C and 60 s at 72°C with 2 sec of extension time for each cycle. Nine microliters of the reaction mix were electrophoresed on an ethidium bromide-stained 1.4% agarose gel, observed under UV-light and blotted with 20 × SSC on to nylon filters (Gene Screen; DuPont, Bad Homburg, Germany) using standard methods. The internal HHV-8 oligonucleotide was labelled with ␥-32 P-ATP (Amersham, Braunschweig, Germany) using T4 polynucleotide kinase (MBI Fermentas, St Leon-Roth, Germany). The hybridization was carried out overnight at 42°C; filters were exposed to Xray films for autoradiography. To determine the quality of the DNA and the PCR amplification, another set of primers was used to amplify monocyte-specific esterase (MSE) (Ref. 16 , and unpublished data). Primers were purchased from Eurogentec (Brussels, Belgium). The authenticity of the PCR product was validated by the following three parameters: (1) positive cell lines displayed the correctly sized amplified bands after electrophoresis of the PCR products: (2) hybridization of the PCR products, Southern-blotted on nylon filters, was demonstrated with the internal oligonucleotide; (3) cell lines known previously to be positive were used as positive controls.
Results and discussion
DNA from all 247 cell lines listed in Table 2 was analyzed after PCR with forward and reverse KS330 233 primers which amplify a 233-bp fragment from the KS330Bam region specific for HHV-8 sequences in genomic DNA 1 ( Figure 1) . To confirm the HHV-8 origin of these amplification products, amplified fragments were transferred to nylon filters and hybridized with a radioactively labelled internal oligonucleotide probe for the 233-bp HHV-8 fragment. In a dilution series, the lower limits of the detection in our DNA PCR was determined to be about 10 fg of genomic DNA. The panel of cell lines derived from solid non-hematopoietic tumors included 133 cell lines, 25 of which were established from tumor material in malignant pleural effusion or ascitic fluid ( Table 2 ). The hematopoietic cell lines comprised 114 lines from the major hematopoietic cell lineages. An extended spectrum of B cell malignancies was examined, including seven PEL-derived cell lines. Overall, 28 hematopoietic cell lines were established from pleural effusions or ascites ( Table 2) .
The results are summarized in Table 2 . Except for the seven PEL cell lines, all solid tumor-derived cell lines and all hematopoietic leukemia-lymphoma cell lines (including all B cell lines like other B-NHL, myeloma, ALL, CLL and other) scored consistently negative for the presence of HHV-8 sequences. HHV-8 infection was also absent in all Hodgkin and ALCLderived cell lines, commonly established from their massive pleural effusions or ascites.
A peculiar finding is the fact that cultured spindle cells from Kaposi's sarcoma have been found to be consistently negative for HHV-8 DNA while these cells are always HHV-8+ in situ. 17 Thus, cultured cells may occasionally lose the virus. As theoretically this may also apply to other types of malignancies, the absence of HHV-8 from cultured cells does not necessarily prove that the primary tumor is negative in situ.
The present investigations underline the association of HHV-8 with PEL (reviewed in Refs 5 and 6). The availability of several PEL-derived cell lines is of great value, both for the study of the pathophysiology of this lymphomatous malig- Table 2 Prevalence ) a In parenthesis, the number of cell lines which were derived from tumor material in malignant pleural effusion or ascitic fluid are indicated for each category. b One cell line in each of the three categories was established from normal cells. ALCL, anaplastic large cell lymphoma; ALL, acute lymphoblastic leukemia; BCBL, body cavity-based lymphoma; BCP, B cell precursor; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia; HCL, hairy cell leukemia; LCL, EBV + lymphoblastoid cell line; NHL, non-Hodgkin's lymphoma; PCL, plasma cell leukemia; PEL, primary effusion lymphoma; PLL, prolymphocytic leukemia.
nancy and for the analysis of the biology of HHV-8 and its presumed pathogenetic role in the development of this disorder.
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